Displaying One Session

View
Controversy session Auditorium 1A

Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?

Date
Fri, 17.06.2022
Time
14:50 - 15:50
Room
Auditorium 1A
Chairs
  • Mansoor Raza Mirza (Copenhagen, Denmark)
  • Domenica Lorusso (Rome, Italy)
Session Description

Click Here to Vote

Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer? Controversy session

Introduction and first vote

Lecture Time
14:50 - 15:00
Speakers
  • Mansoor Raza Mirza (Copenhagen, Denmark)
Session Name
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:50 - 15:50
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer? Controversy session

Pro

Lecture Time
15:00 - 15:20
Speakers
  • Nicoletta Colombo (Milan, Italy)
Session Name
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:50 - 15:50
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer? Controversy session

Con

Lecture Time
15:20 - 15:40
Speakers
  • Ana Oaknin (Barcelona, Spain)
Session Name
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:50 - 15:50
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer? Controversy session

Second vote and conclusions

Lecture Time
15:40 - 15:50
Speakers
  • Domenica Lorusso (Rome, Italy)
Session Name
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:50 - 15:50